ADAMTS13 and thrombotic thrombocytopenic purpura: IgG antibodies against ADAMTS13 are detected in 75–80% of the patients by the functional Bethesda method in acquired TTP; however, remaining patients may have non-neutralizing antibodies often detected by an ELISA46.